|
Status |
Public on Mar 01, 2006 |
Title |
Microarray analysis of in vivo inhibition of mir-122 with an antisense oligonucleotide. |
Organism |
Mus musculus |
Experiment type |
Expression profiling by array
|
Summary |
Current understanding of microRNA (miRNA) biology is limited, and antisense oligonucleotide (ASO) inhibition of miRs is a powerful technique for their functionalization. To uncover the role of the liver-specific miR-122 in the adult liver, we inhibited it in vivo using a 2’-O-methoxyethyl phosphorothioate ASO. This microrarray experiment was used to identify changes in mRNA levels due to the inhibition of miR-122 that accompanied phenotypic observations of reduced cholesterol and triglycerides, increased fatty acid oxidation, and decreased fatty acid and cholesterol synthesis rates observed in hepatocytes. Keywords: single treatment vs. control
|
|
|
Overall design |
The experiment contains two groups of 5 mice: one group treated with an antisense to miR-122, and a second group injected only with saline as a control. RNA was extracted from individual livers, and each of these samples was hybridized to a single-channel chip. The design was intended to permit determination of statistically significant fold changes 1.5 and above.
|
|
|
Contributor(s) |
Esau C |
Citation(s) |
16459310 |
|
Submission date |
Nov 11, 2005 |
Last update date |
Mar 25, 2013 |
Contact name |
Michael Pear |
E-mail(s) |
mpear@isisph.com
|
Phone |
760-603-2779
|
URL |
http://www.isspharm.com
|
Organization name |
Isis Pharmaceuticals, Inc.
|
Department |
Research Informatics
|
Street address |
1896 Rutherford Rd
|
City |
Carlsbad |
State/province |
CA |
ZIP/Postal code |
92009 |
Country |
USA |
|
|
Platforms (1) |
GPL2897 |
GE Healthcare/Amersham Biosciences CodeLink™ Mouse Whole Genome Bioarray |
|
Samples (10)
|
|
Relations |
BioProject |
PRJNA93705 |